New shot aims to quiet gout flare pain quickly
NCT ID NCT06444867
First seen Oct 31, 2025 · Last updated May 02, 2026 · Updated 32 times
Summary
This early-phase study tested a single injection of an experimental drug (LEO 158968) in 6 adults experiencing a gout flare. The main goal was to see if the drug could reduce joint pain to none or mild within a few days. Researchers measured pain using a simple 0-to-4 scale, aiming for a score of 0 or 1 on Day 4 and Day 8 after the shot.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JOINT PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
LEO Pharma Investigational Site
Lille, 59400, France
-
LEO Pharma Investigational Site
Venlo, 5912 BL, Netherlands
-
LEO Pharma Investigational Site
London, EC2Y 8EA, United Kingdom
Conditions
Explore the condition pages connected to this study.